553 filings
4
Mendlein John
20 Jan 23
FATE THERAPEUTICS / JOHN MENDLEIN ownership change
4:14pm
4
Mendlein John
13 Jan 23
FATE THERAPEUTICS / JOHN MENDLEIN ownership change
6:20pm
4
Bahram Valamehr
13 Jan 23
FATE THERAPEUTICS / Bahram Valamehr ownership change
4:02pm
4
J Scott Wolchko
11 Jan 23
FATE THERAPEUTICS / J Scott Wolchko ownership change
4:09pm
4
FATE
Fate Therapeutics Inc
11 Jan 23
FATE THERAPEUTICS / Bahram Valamehr ownership change
4:08pm
4
Cindy Tahl
11 Jan 23
FATE THERAPEUTICS / CINDY TAHL ownership change
4:08pm
4
Mark Plavsic
11 Jan 23
FATE THERAPEUTICS / Mark Plavsic ownership change
4:07pm
4
FATE
Fate Therapeutics Inc
11 Jan 23
FATE THERAPEUTICS / Edward J Dulac III ownership change
4:06pm
4
FATE
Fate Therapeutics Inc
11 Jan 23
FATE THERAPEUTICS / Yu-Waye Chu ownership change
4:05pm
SC 13G/A
BLK
Blackrock Inc.
6 Jan 23
FATE THERAPEUTICS / BlackRock ownership change
12:23pm
8-K
FATE
Fate Therapeutics Inc
5 Jan 23
Termination of a Material Definitive Agreement
5:04pm
8-K
FATE
Fate Therapeutics Inc
7 Nov 22
Fate Therapeutics Announces Exercise by ONO Pharmaceutical of Option to HER2-targeted CAR T-Cell Product Candidate for Solid Tumors
1:21pm
10-Q
2022 Q3
FATE
Fate Therapeutics Inc
3 Nov 22
Quarterly report
4:05pm
8-K
FATE
Fate Therapeutics Inc
3 Nov 22
Fate Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Operational Progress
4:03pm
4
Edward J Dulac III
19 Aug 22
FATE THERAPEUTICS / Edward J Dulac III ownership change
6:58pm
10-Q
2022 Q2
FATE
Fate Therapeutics Inc
3 Aug 22
Quarterly report
4:08pm
8-K
FATE
Fate Therapeutics Inc
3 Aug 22
Fate Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Operational Progress
4:03pm
4
J Scott Wolchko
25 Jul 22
FATE THERAPEUTICS / J Scott Wolchko ownership change
6:18pm
4
Bahram Valamehr
8 Jul 22
FATE THERAPEUTICS / Bahram Valamehr ownership change
4:51pm
4
Bahram Valamehr
7 Jul 22
FATE THERAPEUTICS / Bahram Valamehr ownership change
4:04pm